Journal of Hard Tissue Biology
Online ISSN : 1880-828X
Print ISSN : 1341-7649
ISSN-L : 1341-7649
Original
Lipopolysaccharide and High Concentrations of Glucose Enhances Zoledronate-induced Increase in RANKL/OPG Ratio by Upregulating PGE2 Production in Osteoblasts
Maki NagasakiKumiko NakaiHideki TanakaManami OzakiKengo KatoRyosuke KoshiMasao MaenoShuichi NishikuboTakayuki KawatoMorio Tonogi
著者情報
キーワード: PGE2, RANKL, Osteoprotegerin, Zoledronate
ジャーナル フリー

2021 年 30 巻 1 号 p. 37-44

詳細
抄録

Preexisting diseases, such as diabetes and chronic inflammation in periodontal tissue, are risk factors associated with bisphosphonate-related osteonecrosis of the jaw. Osteoblasts produce prostaglandin (PG)E2 via cyclooxygenases (COX), and the autocrine action of PGE2 impacts the function of osteoblasts, including receptor activator of NF-kappa B ligand (RANKL) and osteoprotegerin (OPG) production. This study assessed the effects of the stimulation of zoledronate in the presence of lipopolysaccharide (LPS) and high concentrations of glucose on the expression of COX-2, RANKL, and OPG, in addition to PGE2 production in osteoblasts. MG-63 cells were cultured in medium containing 1 µg/ml LPS, 25 mM glucose (high glucose), and/or zoledronate (1×10-8, 1×10-7, 1×10-6, 5×10-6, or 1×10-5 M). The mRNA expression of COX-2, RANKL, and OPG genes was determined by real-time polymerase chain reaction. The concentrations of RANKL and OPG protein and PGE2 in the culture supernatant were examined by enzyme-linked immunosorbent assay. Zoledronate at a concentration of 5×10-6 M overwhelmingly increased COX-2 mRNA expression. The expression levels of RANKL and OPG as well as PGE2 production was significantly increased in cells stimulated with 5×10-6 M zoledronate in the presence of LPS and high glucose than in the unstimulated cells (control). NS398, a specific inhibitor of COX-2, blocked the stimulatory effects of zoledronate (in the presence of LPS and high glucose) on PGE2 production and the protein expression levels of RANKL and OPG. The ratio of RANKL/OPG was also increased following zolendronate stimulation. In addition, a significant difference was observed not in the stimulation with zoledronate alone, but by the stimulation of zoledronate in the presence of LPS and high glucose as compared that in controls. These results suggest that LPS and high concentrations of glucose enhances zoledronate-induced increase in RANKL/OPG ratio via the autocrine action of NS398-blocked PGE2 in osteoblasts.

著者関連情報
© 2021 by The Hard Tissue Biology Network Association(JHTBNet)
前の記事 次の記事
feedback
Top